INTRODUCTION
============

Antibiotics have been used as feed additives for the purpose of preventing disease, promoting growth, and improving feed efficiency in animals. As antibiotics can remain in livestock products such as meat, eggs, and milk causing antibiotic resistance in humans, their use is increasingly banned across countries. Recently, the number of antibiotics used as feed additives has been reduced from 53 to 23, and among the antibiotics used in 25 feed additives, the tetracycline series and seven generic antibiotics have been banned \[[@b1-ajas-31-3-429]\]. Due to these antibiotic restrictions in feed additives, various natural resource materials have been developed.

*Rubus coreanus* (RC) is a deciduous shrub belonging to the *Rosaceae* family and generally contains 87.0 g of water, 1.6 g of protein, 1.7 g of fat, 1.3 g of glucose, 2.9 g of fiber and 0.5 g of ash in 100 g as well as Ca, Mg, Na and Fe and vitamins such as vitamin A, vitamin B1, and vitamin C \[[@b2-ajas-31-3-429]\]. It has been reported that organic acids such as gallic acid, polyphenols such as quercetin, kaempferol, and tannins in RC have various anticancer, antioxidant, cholesterol-lowering and anti-obesity effects \[[@b3-ajas-31-3-429]\]. In addition, ellagitannins and ellagic acid, which possess anti-cancer, anti-diabetic and anti-inflammatory effects, are very poorly absorbed by the gastrointestinal system and the unabsorbed compounds are metabolized to urolithin by intestinal microorganisms \[[@b4-ajas-31-3-429]\]. As the activity of useful ingredients in RC has been reported, various functional products are attracting attention. The byproducts account for approximately 20% of the RC juice extracts, but are mostly being discarded \[[@b5-ajas-31-3-429]\]. The hot water extract of RC byproducts contains 8.9% of organic acid, 69.9% of neutral sugar, 19.1% of pectin and 5.2% of anthocyanin \[[@b6-ajas-31-3-429]\].

Although studies on the polyphenol content \[[@b7-ajas-31-3-429]\] of RC byproducts using ethanol concentration have been reported, studies using RC byproducts have not been performed yet. Therefore, this study was conducted to investigate the effects of RC byproducts on intestinal microbes and the immune system in white rats. This may prove useful for the production of functional products using RC.

MATERIALS AND METHODS
=====================

Feed and experimental animal feeding experiment
-----------------------------------------------

The RC byproducts used in this experiment were obtained by generating a RC extract, drying the remaining byproducts (peel, seed) in a 50°C dry oven for 24 hours and then grinding them into a powder. Six-week-old male Sprague-Dawley rats were purchased from Samtako (Osan, Korea). A total of 6 rats were used in each treatment group, which were further divided into six repetitions consisting of one rat per repetition. The rats were subjected to a basal diet (AIN-76, Feed Lab, Guri, Korea) (Control group), a basal diet mixed with 0.5% dried RC byproduct powder (T1 group), a basal diet mixed with 1.0% dried RC byproduct powder (T2 group), and a basal diet mixed with 1.5% dried RC byproduct powder (T3 group). The animal housing was maintained at a temperature of 22°C ±3°C, relative humidity of 55%±5%, and light and dark cycles of 12 hours each. The rats underwent a 7-day acclimatization period before subjecting them to the aforementioned diets for 4 weeks, and the feed and drinking water were provided *ad libitum*. The weight and feed intake of each rat were measured once weekly throughout the experimental period. All procedures were approved by the Institutional Animal Care and Use Committees at Gyeongnam National University of Science and Technology (No. 2016--10).

DNA extraction and Illumina sequencing
--------------------------------------

All animals were sacrificed by diethyl ether and fecal samples of the rats were collected and stored at −80°C until genomic DNA (gDNA) extraction. DNA was extracted using Fecal DNA MiniPrep kits (Zymo Research, Irvine, CA, USA), and the sequence was analyzed using Illumina MiSeq (Chunlab Inc., Seoul, Korea) \[[@b8-ajas-31-3-429]\].

Quantitative polymerase chain reaction
--------------------------------------

As mentioned above, DNA was extracted from rat fecal samples. Quantitative polymerase chain reaction (qPCR) was performed using Rotor-Gene SYBR Green PCR Kits and Rotor-Gene Q (Qiagen, Hilden, Germany). The PCR cycling conditions were as follows: 40 cycles of 95°C for 10 s, 56°C for 30 s, 72°C for 10 s. Universal primer was used as the reference gene ([Table 1](#t1-ajas-31-3-429){ref-type="table"}).

Separation and analysis of RNA from rat spleen and mesenteric lymph nodes and RT-PCR
------------------------------------------------------------------------------------

To analyze the immunomodulatory effects of the RC byproducts, rats were sacrificed and mesenteric lymph nodes (MLNs) and spleen were separated. Trizol was added to MLN and spleens and they were homogenized using SilentCrusher M (Heidolph, Schwabach, Germany). RNA was extracted and stored at −20°C until cDNA synthesis using reverse transcription-PCR (RT-PCR) kits (TaKaRa Co., Tokyo, Japan) according to the manufacturer's instructions. RT-PCR (GeneAMP PCR System 9700; Thermo Fisher Scientific Inc., Waltham, MA, USA) cycling conditions are as follows: initial denaturation step at 50°C for 30 min, 94°C for 2 min, followed by 35 cycles of 94°C for 30 s, 55°C for 30 s, and 72°C for 59 s, and a final extension step at 72°C for 2 min. Glyceraldehyde-3-phosphate dehydrogenase was used as the reference gene ([Table 2](#t2-ajas-31-3-429){ref-type="table"}).

Statistical analysis
--------------------

All results are shown as means±standard deviation and the variance of the results obtained through repeated experiments was analyzed using SPSS 12.0 (SPSS Inc., Chicago, IL, USA). The significance of the results was tested using Duncan's multiple range test at a level of p\<0.05.

RESULTS
=======

Body weight, daily gain, daily feed intake and feed efficiency in rats
----------------------------------------------------------------------

Rats in the T3 RC byproduct-fed group showed the greatest increase in both average daily gain and average daily feed intake ([Table 3](#t3-ajas-31-3-429){ref-type="table"}). The treatments with T1, T2, and T3 caused a marked feed efficiency when compared to the control group.

mRNA expression of galectin-9 in MLN and spleen
-----------------------------------------------

Galectin-9 is known to induce a Treg-mediated immune response \[[@b9-ajas-31-3-429]\]. We performed RT-PCR analysis to investigate whether RC byproducts can increase the mRNA expression of galectin-9 in MLNs and spleens of the rats. mRNA expression of galectin-9 was significantly increased in MLNs as well as spleens from the RC-treated (T1, T2, and T3) rats compared to that in the control group. In addition, the treatment with T1 caused the highest increase in the mRNA expression of galectin-9 in MLN ([Figure 1](#f1-ajas-31-3-429){ref-type="fig"}).

Th1/Th2 balance and the development of Treg cells in MLN and spleen
-------------------------------------------------------------------

In order to investigate whether T cell polarization is influenced by RC, we evaluated the expression of the transcription factors T-box expressed in T cells (T-bet) for Th1, GATA binding protein 3 (GATA 3) for Th2, RAR-related orphan receptor gamma T (RORγT) for Th17 and forkhead box P3 (Foxp3) for Treg cells in the MLN and spleen. In the MLN, the expression of T-bet and Foxp3 were increased, while the expression of GATA-3 and RORγT were decreased in the T1, T2, and T3 treatment groups compared to that in the control group ([Figures 2A--2D](#f2-ajas-31-3-429){ref-type="fig"}). Th1/Th2 and Treg/Th2 ratios were significantly increased in a dose-dependent manner in rats fed with T1, T2, and T3, inducing a Th1 and Treg cell-mediated immunity response ([Figures 2E, 2G](#f2-ajas-31-3-429){ref-type="fig"}). However, the Treg/Th1 ratio was decreased and the Treg/(Th1+Th2) ratio was not changed ([Figures 2E--2H](#f2-ajas-31-3-429){ref-type="fig"}). Consistent with the results in the MLN, T-bet and Foxp3 expression were increased in the T1, T2, and T3 treatment groups ([Figures 3A, 3D](#f3-ajas-31-3-429){ref-type="fig"}), whereas GATA-3 and RORγT expression were decreased in the spleen compared to that in the control group ([Figures 3B, 3C](#f3-ajas-31-3-429){ref-type="fig"}). The ratios of Th1/Th2 and Treg/Th1, and Treg/Th2 were increased to induce Th1 and Treg cell-mediated immunity ([Figures 3E--3G](#f3-ajas-31-3-429){ref-type="fig"}). The ratio of Treg/(Th1+Th2) was also increased by T1, T2, and T3 treatment ([Figure 3H](#f3-ajas-31-3-429){ref-type="fig"}). Therefore, these results indicate that RC *byproducts can improve rat immunity by enhancing Treg cell*s in the MLN and spleen.

Intestinal microbiological environment in rats
----------------------------------------------

When rats were supplied with T1, T2, and T3, *Firmicutes* (F) levels in the intestinal microflora were markedly decreased while *Bacteroidetes* (B) levels were increased in a dose-dependent manner ([Figure 4](#f4-ajas-31-3-429){ref-type="fig"}). The *F/B* ratio was decreased depending on the concentration of T1, T2, and T3. Particularly, *Clostridia* from the phylum *Firmicutes* and pathogenic microorganisms belonging to the *Peptococcaceae* decreased by the consumption of T1, T2, and T3, and the non-pathogenic *Lachnospiraceae* and *Ruminococcaceae* microorganisms increased ([Table 4](#t4-ajas-31-3-429){ref-type="table"}). Among the class *Bacteroidia*, which occupies most of the *Bacteroidetes*, the number of microbes belonging to the non-pathogenic *S24-7* and *Rikenellaceae* family increased. These results show that microorganisms promoting intestinal health were increased in rats fed with RC byproducts.

Microorganisms showing obesity, anti-obesity, and butyrate-producing traits
---------------------------------------------------------------------------

Rats fed with T1, T2, and T3 byproducts showed a decrease in anti-obesity microorganisms, while an increase in obesity- and butyrate-producing microorganisms occurred in a concentration-dependent manner ([Figure 5](#f5-ajas-31-3-429){ref-type="fig"}). Therefore, these data suggest that RC byproducts can improve intestinal health by increasing the number of butyrate-producing microorganisms.

Intestinal lactic acid bacteria and intestinal microflora
---------------------------------------------------------

The qPCR analysis showed that RC byproducts induced 12 intestinal probiotics and microorganisms compared to that in the control group. Particularly, *Bifidobacterium* spp., *Leuconostoc citreum*, *Weissella cibaria*, *Oscillospira* spp. showed the most prominent increase ([Figure 6](#f6-ajas-31-3-429){ref-type="fig"}).

DISCUSSION
==========

The RC byproducts account for approximately 20% of the bokbunja juice extract, but are mostly being discarded \[[@b5-ajas-31-3-429]\]. There have been some studies on the general components and polyphenol contents of RC byproducts \[[@b6-ajas-31-3-429],[@b7-ajas-31-3-429]\]. To observe the effects of these byproducts on the intestinal microorganism environment and immune system of experimental animals, MLN and spleen mRNA was purified and analyzed for the composition of intestinal microorganisms via pyro-sequencing, and by investigating the mechanisms of immune function regulation. The expression of galectin-9 in the MLNs and spleens of rats fed 0.5%, 1.0%, and 1.5% RC was higher than that of the control group. This implies that RC byproducts can activate galectin-9 in the body. Previous studies have shown that galectin-9 induces Treg cell immune responses and neutralizes immunoglobulin E antibodies \[[@b10-ajas-31-3-429]\]. In addition, RC byproducts activated the mRNA expression of galectin-9 in the MLN and spleen with increased T-bet and Foxp3 as a reflection of Th1 and Treg cells, respectively. T-bet and Foxp3 could bind to multiple distal sites at immune regulatory genes for T cell fate determination as transcription factors \[[@b11-ajas-31-3-429]\]. This is consistent with the results of Kivit et al \[[@b12-ajas-31-3-429]\] who showed that galectin-9 induces Th1 and Treg cell development and increases interferon-γ and interleukin-10 secretion to suppress the allergic response and regulate immunity \[[@b12-ajas-31-3-429]\]. In addition, galectin-9, which induces apoptosis of T cells, inhibited the activation level of Treg/Th1 immune factors. Therefore, the RC byproducts activate the expression of galectin-9, and the activated galectin-9 promotes Th 1 and Treg immune responses and thus induces immunomodulation.

The mammalian intestinal microbiome is composed of hundreds of millions of microorganisms and could affect host metabolism and diseases such as obesity, arteriosclerosis, and type 2 diabetes. In addition to the host's metabolism, these microbes also provide many advantages, including the development of the immune system and maintenance of the epithelial barrier \[[@b13-ajas-31-3-429]\]. *Firmicutes* and *Bacteroidetes* are the predominant phyla living in the intestine of humans and most mammals, and *Proteobacteria*, *Actinobacteria*, and *Tenericutes* together constitute other phyla \[[@b14-ajas-31-3-429]\]. *Bacteroidetes* \[[@b15-ajas-31-3-429]\], which contribute to defense against potential pathogens in the intestine, are increased by RC byproducts in the diet. The increase in *Bacteroidetes* is associated with a decrease in metabolic syndrome indicators such as high cholesterol and blood pressure \[[@b16-ajas-31-3-429]\]. Patients with type 1 diabetes or hypertension have increased intestinal levels of *Firmicutes*, which in turn increases the ratio of *Firmicutes/Bacteroidetes* \[[@b17-ajas-31-3-429]\]. Rats treated with RC byproducts showed a relative decrease of Firmicutes, and the ratio of Firmicutes/Bacteroidetes decreased in a concentration-dependent manner. The family *Peptococcaceae* in the *Clostridia* class consists of pathogenic microorganisms showing a positive correlation with CCL5, an inflammation-inducing cytokine, and decreased in response to RC treatment \[[@b18-ajas-31-3-429]\]. *Lachnospiraceae* and *Ruminococcaceae* of class *Clostridia*, the levels of which increase when RC byproducts are given, are microorganisms associated with metabolic health \[[@b19-ajas-31-3-429]\]. It is also known that RC produces intestinal anti-inflammatory compounds and butyrate which has immunomodulating properties \[[@b20-ajas-31-3-429]\]. The increased levels of microbes in the *S24-7* family in the *Bacteroidia* class act as a protective factor for diabetes \[[@b21-ajas-31-3-429]\], while *Rikenellaceae* alter the intestinal environment and exhibit antitumor effects \[[@b22-ajas-31-3-429]\]. The decrease in pathogenic microorganisms and the increase in non-pathogenic microorganisms suggest that intestinal health is enhanced by RC byproducts in rats. The bioavailability of ellagitannins and ellagic acid in RC byproducts is very low. These molecules are converted by intestinal microorganisms to urolithin, which is much better absorbed in the body \[[@b23-ajas-31-3-429]\]. Urolithin production is more abundant in *Firmicutes*, especially in *Clostridium leptum*, than in *Bacteroidetes* \[[@b24-ajas-31-3-429]\]. Urolithin is a microflora metabolite of ellagic acid derivatives \[[@b25-ajas-31-3-429]\], which enhances anti-proliferative, anti-inflammatory, and vascular endothelial function in cancer cell models \[[@b26-ajas-31-3-429]\]. Dietary fibers, such as RC byproducts, are fermented by microorganisms in the large intestine to produce short-chain fatty acids containing butyric acid \[[@b27-ajas-31-3-429]\]. Butyrate-producing microorganisms belong to the *Firmicutes*, and among them, *Ruminococcus*, *Roseburia*, and *Eubacterium* are prominent examples \[[@b28-ajas-31-3-429]\]. *Bifidobacterium* spp. is an important microorganism with immunomodulatory and anticancer activity \[[@b29-ajas-31-3-429]\], and its levels increased when bifidobacterial byproducts were ingested. In rats fed with RC byproducts, levels of butyrate-producing microorganisms increased, leading to improved intestinal health. In conclusion, the consumption of RC byproducts increased the expression of Th1 and Treg cell transcription factors and galectin-9 in this study. In addition, the intestinal environment was changed by decreasing *Firmicutes*, increasing *Bacteroidetes*, and decreasing the *Firmicutes/Bacteroidetes* ratio. This suggests that bokbunja byproducts improve immune function and promote bowel health.
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![Rat fed *Rubus coreanus* byproducts show enhanced galectin-9 development in mesenteric lymph nodes (MLN) and spleen. C, control; T1, 0.5% *Rubus coreanus* byproducts; T2, 1.0% *Rubus coreanus* byproducts; T3, 1.5% *Rubus coreanus* byproducts. The expression of galectin-9 in MLN was higher in the group fed with *Rubus coreanus* byproducts than in control, and highest in the group of 0.5% *Rubus coreanus* byproducts. Galectin-9 expression in the spleen was also higher in the group fed with *Rubus coreanus* byproducts than in control. a-c Means are significantly different within the same row (p\<0.05). Data represent means±standard deviation of 6 replicates.](ajas-31-3-429f1){#f1-ajas-31-3-429}

![Rat fed *Rubus coreanus* byproducts show enhanced Treg-cell development in mesenteric lymph nodes (MLN). C, control; T1, 0.5% *Rubus coreanus* byproducts; T2, 1.0% *Rubus coreanus* byproducts; T3, 1.5% *Rubus coreanus* byproducts. T-cell polarization in MLN was evaluated by analyzing the expression of T-bet (Th1, A), GATA binding protein 3 (GATA-3) (Th2, B), RAR-related orphan receptor gamma T (RORγT) (Th17, C) and forkhead box P3 (Foxp3) (Treg, D). The expression of Foxp3 tended to increase in rat fed *Rubus coreanus* byproducts, while GATA-3 and RORγT expression was decreased. Expression of T-bet was no changed. Rat fed *Rubus coreanus* byproducts showed an increased Th1/Th2 (E) and Treg/Th2 ratio (F), but the Treg/Th1 ratio decreased (G). The ratio between Treg cells and effector Th1 and Th2 cells (H) was no changed. ^a--c^ Means are significantly different within the same row (p\<0.05). Data represent means±standard deviation of 6 replicates.](ajas-31-3-429f2){#f2-ajas-31-3-429}

![Rat fed *Rubus coreanus* byproducts show enhanced Treg-cell development in spleen. C, Control; T1, 0.5% *Rubus coreanus* byproducts; T2, 1.0% *Rubus coreanus* byproducts; T3, 1.5% *Rubus coreanus* byproducts. T-cell polarization in spleen was evaluated by analyzing the expression of T-box expressed in T cells (T-bet) (Th1, A), GATA binding protein 3 (GATA-3) (Th2, B), RAR-related orphan receptor gamma T (RORγT) (Th17, C) and forkhead box P3 (Foxp3) (Treg, D). The expression of Foxp3 tended to increased in rat fed *Rubus coreanus* byproducts, while GATA-3 and RORγT expression was decreased. Expression of T-bet was no changed. Rat fed *Rubus coreanus* byproducts showed an increased Th1/Th2 (E) and Treg/Th2 ratio (F), but the Treg/Th1 ratio decreased (G). The ratio between Treg cells and effector Th1 and Th2 cells (H) was increased. ^a--c^ Means are significantly different within the same row (p\<0.05). Data represent means±standard deviation of 6 replicates.](ajas-31-3-429f3){#f3-ajas-31-3-429}

![Effects of dietary supplementation of *Rubus coreanus* byproducts on diversity of phyla of Intestinal microbiota in rats. C, control; T1, 0.5% *Rubus coreanus* byproducts; T2, 1.0% *Rubus coreanus* byproducts; T3, 1.5% *Rubus coreanus* byproducts. Duncan's multiple range test was used to show the *Firmicutes* and *Bacteroidetes* contents and F/B ratios of each sample at the phylum level. F/B ratio was reduced by *Rubus coreanus* byproducts. ^a--c^ Means are significantly different within the same row (p\<0.05). Data represent means±standard deviation of 6 replicates.](ajas-31-3-429f4){#f4-ajas-31-3-429}

![Rat fed *Rubus coreanus* byproducts show relatively changed intestinal microorganisms. C, control; T1, 0.5% *Rubus coreanus* byproducts; T2, 1.0% *Rubus coreanus* byproducts; T3, 1.5% *Rubus coreanus* byproducts. The relative abundance of obesity microorganism (*Roseburia*, *Eubacterium_g8*, *Pseudoflavonifractor*, *Ruminococcaceae_uc*, *Ruminococcus*, *JN713389_g*, *Eubacterium_g23*, *AB185816_g*, *Caproiciproducens*, *Ruminococcus_g2*, *JQ084194_g*, *Subdoligranulum*, *Oscillibacter*, *Butyricicoccus*, *EF602946_g*, *Allobaculum*, *Erysipelotrichaceae_uc*, *Coprobacillus*, *Faecalibaculum*, *EF445272_g*; (A) and antiobesity microorganism (*Bacteroides*, *Parabacteroides*, *Prevotella*, *Prevotellaceae_uc*, *Alistipes*, *AB239481_g*, *Christensenellaceae_uc*, *HM124260_g*, *GU302849_g*, *Christensenella*, *Bacteroides_g1*; (B) tended to increase in rat fed *Rubus coreanus* byproducts, while butyric acid microorganism (*Eubacterium_g17*, *Eubacterium_g4*, *Roseburia*, *Eubacterium_g6, Eubacterium_g20*, *Eubacterium_g21*, *Eubacterium_g8*, *Pseudoflavonifractor*, *Ruminococcaceae_uc*, *Ruminococcus*, *JN713389_g*, *Eubacterium_g23*, *AB185816_g*, *Caproiciproducens*, *Ruminococcus_g2*, *JQ084194_g*, *Subdoligranulum*, *Oscillibacter*, *Anaerotruncus*, *Butyricicoccus*, *EF602946_g*, *Phascolarctobacterium*, *Clostridium_g21*, *AB606237_g*, *FJ880395_g*, *Blautia*, *JPZU_g*, *AJ576336_g*, *AB606254_g*, *HM123979_g*, *Coprococcus_g2*, *Ruminococcus_g4*, *GU324393_g*, *Murimonas*, *EU509117_g*, *Marvinbryantia*; (C) relative abundance was decreased. Data represent means±standard deviation of 6 replicates.](ajas-31-3-429f5){#f5-ajas-31-3-429}

![Rat fed *Rubus coreanus* byproducts show increased intestinal lactobacilli and microorganisms by quantitative polymerase chain reaction (qPCR). C, control; T1, 0.5% *Rubus coreanus* byproducts; T2, 1.0% *Rubus coreanus* byproducts; T3, 1.5% *Rubus coreanus* byproducts. The expression of *Bifidobacterium* spp., *Leuconostoc citreum*, *Weissella cibaria* and *Oscillospira* spp. tended to increased in rat fed *Rubus coreanus* byproducts. ^a--c^ Means are significantly different within the same row (p\<0.05). Data represent means±standard deviation of 6 replicates.](ajas-31-3-429f6){#f6-ajas-31-3-429}

###### 

Quantitative real-time polymerase chain reaction primer design

  Target group/specificity            Primer sequence   
  ----------------------------------- ----------------- ---------------------------
  Universal                           Forward           GTGSTGCAYGGYYGTCGTCA
                                      Reverse           ACGTCRTCCMCNCCTTCCTC
  *Bacteroides* spp.                  Forward           GAAGGTCCCCCACATTG
                                      Reverse           CGCKACTTGGCTGGTTCAG
  *Roseburia* spp. and *E. rectale*   Forward           GCGGTRCGGCAAGTCTGA
                                      Reverse           CCTCCGACACTCTAGTMCGAC
  *Faecalibacterium prausnitzii*      Forward           GGAGGAAGAAGGTCTTCGG
                                      Reverse           AATTCCGCCTACCTCTGCACT
  Cluster IV *Ruminococcus* spp.      Forward           GGCGGCYTRCTGGGCTTT
                                      Reverse           CCAGGTGGATWACTTATTGTGTTAA
  *Bifidobacterium* spp.              Forward           TCGCGTCYGGTGTGAAAG
                                      Reverse           GGTGTTCTTCCCGATATCTACA
  Methanogens                         Forward           GGATTAGATACCCSGGTAGT
                                      Reverse           GTTGARTCCAATTAAACCGCA
  *Oscillospira* spp.                 Forward           ACGGTACCCCTTGAATAAGCC
                                      Reverse           TCCCCGCACACCTAGTATTG
  *Leuconostoc mesenteroid*           Forward           TGATGCATAGCCGAGTTGAG
                                      Reverse           GAAAGCCTTCATCACACACG
  *Leuconostoc citreum*               Forward           GGAAACAGATGCTAATACCGAATA
                                      Reverse           TTTACCCCACCAACTAACTAATG
  *Weissella cibaria*                 Forward           GGGAAACCTACCTCTTAGCA
                                      Reverse           GGACCATCTCTTAGTGATAGCA
  *Weissella koreensis*               Forward           GGGCTACACACGTGCTACAA
                                      Reverse           GATTCCGACTTCGTGTAGGC
  *Lactobacillus sakei*               Forward           CCATGTGTAGCGGTGAAATG
                                      Reverse           ATCCTGTTTGCTACCCATGC

###### 

Reverse transcriptase polymerase chain reaction primer design

  Target group/specificity   Primer sequence   
  -------------------------- ----------------- --------------------------
  *TGF-β*                    Forward           GAAGGCAGAGTTCAGGGTCTT
                             Reverse           GGTTCCTGTCTTTGTGGTGAA
  *IL-10*                    Forward           ATAACTGCACCCACTTCCCA
                             Reverse           TCATTTCCGATAAGGCTTGG
  *IFN-γ*                    Forward           TCAAGTGGCATAGATGTGGAAGAA
                             Reverse           TGGCTCTGCAGGATTTTCATG
  *IL-17A*                   Forward           TTCATCTGTGTCTCTGATGCT
                             Reverse           TTGACCTTCACATTCTGGAG
  *IL-4*                     Forward           ACAGGAGAAGGGACGCCAT
                             Reverse           GAAGCCCTACAGACGAGCTCA
  *Foxp3*                    Forward           CCCATCCCCAGGAGTCTTG
                             Reverse           CCATGACTAGGGGCACTGTA
  *GATA3*                    Forward           CATTACCACCTATCCGCCCTATG
                             Reverse           CACACACTCCCTGCCTTCTGT
  *T-bet*                    Forward           TCAACCAGCACCAGACAGAG
                             Reverse           AAACATCCTGTAATGGCTTGTG
  *RORγt*                    Forward           TTCACCCCACCTCCACTG
                             Reverse           TGCAAGGGATCACTTCAATTT

*TGF-β*, transforming growth factor beta; *IL-10*, interleukin-10; *IFN-γ*, interferon-γ; *Foxp3*, forkhead box P3; *GATA3*, GATA binding protein 3; *T-bet*, T-box expressed in T cells; *RORγt*, Rar-related orphan receptor gamma T.

###### 

Rat fed *Rubus coreanus* byproducts weight gain, daily feed intake, and feed efficiency

                                  C[1)](#tfn4-ajas-31-3-429){ref-type="table-fn"}            T1                                                         T2                                                         T3
  ------------------------------- ---------------------------------------------------------- ---------------------------------------------------------- ---------------------------------------------------------- ----------------------------------------------------------
  Initial body weight (g)         220.34±0.53                                                220.05±0.79                                                220.21±0.48                                                219.90±0.70
  Finished body weight (g)        308.45±0.17[a](#tfn6-ajas-31-3-429){ref-type="table-fn"}   307.38±0.22[a](#tfn6-ajas-31-3-429){ref-type="table-fn"}   308.18±0.88[a](#tfn6-ajas-31-3-429){ref-type="table-fn"}   311.35±0.97[b](#tfn6-ajas-31-3-429){ref-type="table-fn"}
  Average daily gain (g)          3.15±0.02[a](#tfn6-ajas-31-3-429){ref-type="table-fn"}     3.12±0.02[a](#tfn6-ajas-31-3-429){ref-type="table-fn"}     3.14±0.04[a](#tfn6-ajas-31-3-429){ref-type="table-fn"}     3.27±0.04[b](#tfn6-ajas-31-3-429){ref-type="table-fn"}
  Average daily feed intake (g)   20.49±0.68[c](#tfn6-ajas-31-3-429){ref-type="table-fn"}    17.93±0.39[a](#tfn6-ajas-31-3-429){ref-type="table-fn"}    18.67±0.19[b](#tfn6-ajas-31-3-429){ref-type="table-fn"}    19.19±0.40[b](#tfn6-ajas-31-3-429){ref-type="table-fn"}
  Feed efficiency                 0.15±0.005[a](#tfn6-ajas-31-3-429){ref-type="table-fn"}    0.17±0.004[b](#tfn6-ajas-31-3-429){ref-type="table-fn"}    0.17±0.003[b](#tfn6-ajas-31-3-429){ref-type="table-fn"}    0.17±0.003[b](#tfn6-ajas-31-3-429){ref-type="table-fn"}

SD, standard deviation; ADG, average daily gain; ADFI, average daily feed intake.

Data represent means±standard deviation of 6 replicates.

C, control; T1, 0.5% *Rubus coreanus* byproducts; T2, 1.0% *Rubus coreanus* byproducts; T3, 1.5% *Rubus coreanus* byproducts.

ADG, ADFI and feed efficiency increased when *Rubus coreanus* byproducts were fed as compared to control.

Means are significantly different within the same row (p\<0.05).

###### 

The mean of the relative abundance of dominant phyla, classes and familia in fecal sample obtained from rat

  Items[2)](#tfn10-ajas-31-3-429){ref-type="table-fn"}   Treatments[1)](#tfn9-ajas-31-3-429){ref-type="table-fn"}                                                                                                                                 
  ------------------------------------------------------ ------------------------------------------------------------ ------------------------------------------------------------- ------------------------------------------------------------- ------------------------------------------------------------
  ***Firmicutes***                                       85.79 (3.68)[c](#tfn11-ajas-31-3-429){ref-type="table-fn"}   80.90 (2.97)[b](#tfn11-ajas-31-3-429){ref-type="table-fn"}    76.45 (2.77)[a](#tfn11-ajas-31-3-429){ref-type="table-fn"}    74.96 (2.56)[a](#tfn11-ajas-31-3-429){ref-type="table-fn"}
   ***Clostridia***                                      68.49 (3.19)[b](#tfn11-ajas-31-3-429){ref-type="table-fn"}   65.01 (1.71)[a](#tfn11-ajas-31-3-429){ref-type="table-fn"}    63.13 (2.80)[a](#tfn11-ajas-31-3-429){ref-type="table-fn"}    65.05 (2.08)[a](#tfn11-ajas-31-3-429){ref-type="table-fn"}
    *Lachnospiraceae*                                    39.74 (2.21)[a](#tfn11-ajas-31-3-429){ref-type="table-fn"}   40.50 (2.78)[a](#tfn11-ajas-31-3-429){ref-type="table-fn"}    42.10 (2.16)[ab](#tfn11-ajas-31-3-429){ref-type="table-fn"}   44.93 (2.24)[b](#tfn11-ajas-31-3-429){ref-type="table-fn"}
    *Ruminococcaceae*                                    19.32 (4.18)                                                 19.84 (2.06)                                                  19.59 (2.80)                                                  18.40 (1.78)
    *Peptococcaceae*                                     3.19 (0.19)[c](#tfn11-ajas-31-3-429){ref-type="table-fn"}    1.31 (0.15)[b](#tfn11-ajas-31-3-429){ref-type="table-fn"}     0.16 (0.07)[a](#tfn11-ajas-31-3-429){ref-type="table-fn"}     0.13 (0.04)[a](#tfn11-ajas-31-3-429){ref-type="table-fn"}
   ***Bacilli***                                         15.86 (2.04)[c](#tfn11-ajas-31-3-429){ref-type="table-fn"}   13.11 (1.80)[b](#tfn11-ajas-31-3-429){ref-type="table-fn"}    10.95 (1.23)[a](#tfn11-ajas-31-3-429){ref-type="table-fn"}    8.90 (1.96)[a](#tfn11-ajas-31-3-429){ref-type="table-fn"}
    *Lactobacillaceae*                                   15.37 (2.81)[c](#tfn11-ajas-31-3-429){ref-type="table-fn"}   12.71 (2.76)[bc](#tfn11-ajas-31-3-429){ref-type="table-fn"}   10.50 (2.92)[ab](#tfn11-ajas-31-3-429){ref-type="table-fn"}   8.60 (1.41)[a](#tfn11-ajas-31-3-429){ref-type="table-fn"}
  ***Bacteroidetes***                                    11.23 (2.50)[a](#tfn11-ajas-31-3-429){ref-type="table-fn"}   17.14 (2.05)[b](#tfn11-ajas-31-3-429){ref-type="table-fn"}    21.95 (2.76)[c](#tfn11-ajas-31-3-429){ref-type="table-fn"}    23.77 (3.07)[c](#tfn11-ajas-31-3-429){ref-type="table-fn"}
   ***Bacteroidia***                                     10.84 (1.25)[a](#tfn11-ajas-31-3-429){ref-type="table-fn"}   16.82 (2.50)[b](#tfn11-ajas-31-3-429){ref-type="table-fn"}    21.74 (1.91)[c](#tfn11-ajas-31-3-429){ref-type="table-fn"}    23.38 (1.98)[c](#tfn11-ajas-31-3-429){ref-type="table-fn"}
    *S24-7_f*                                            7.33 (1.02)[a](#tfn11-ajas-31-3-429){ref-type="table-fn"}    8.98 (1.71)[a](#tfn11-ajas-31-3-429){ref-type="table-fn"}     11.32 (2.17)[b](#tfn11-ajas-31-3-429){ref-type="table-fn"}    14.95 (1.59)[c](#tfn11-ajas-31-3-429){ref-type="table-fn"}
    *Prevotellaceae*                                     1.28 (0.74)[a](#tfn11-ajas-31-3-429){ref-type="table-fn"}    6.08 (1.90)[c](#tfn11-ajas-31-3-429){ref-type="table-fn"}     6.68 (1.77)[c](#tfn11-ajas-31-3-429){ref-type="table-fn"}     3.40 (1.00)[b](#tfn11-ajas-31-3-429){ref-type="table-fn"}
    *Rikenellaceae*                                      1.68 (0.57)[a](#tfn11-ajas-31-3-429){ref-type="table-fn"}    1.16 (0.52)[a](#tfn11-ajas-31-3-429){ref-type="table-fn"}     2.88 (1.48)[b](#tfn11-ajas-31-3-429){ref-type="table-fn"}     4.29 (1.08)[c](#tfn11-ajas-31-3-429){ref-type="table-fn"}

SD, standard deviation.

Data represent means±SD of 6 replicates.

C, control; T1, 0.5% *Rubus coreanus* byproducts; T2, 1.0% *Rubus coreanus* byproducts; T3, 1.5% *Rubus coreanus* byproducts.

Statistical tests of over-or under-representation of bacterial lineages among at each sample were made at the phylum (bold), class (bold) and family levels using Duncan\'s multiple range test. Rat fed *Rubus coreanus* byproducts show *Firmicutes* decreased and Bacteroidetes increased.

Means are significantly different within the same row (p\<0.05).

[^1]: These authors contributed equally to this study.
